Previous studies have reported that TRIM31 plays a critical role in regulating inflammatory responses [18] and is implicated in the pathogenesis of several metabolic diseases, including non-alcoholic fatty liver disease [35], hypertensive nephropathy [16], and liver fibrosis [36]. This evidence concerns the gene TRIM31 and metabolic dysfunction-associated steatotic liver disease.